Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis

被引:77
作者
Mok, Chi Chiu [1 ]
Penn, Hannah J. [2 ]
Chan, Kar Li [1 ]
Tse, Sau Mei [1 ]
Langman, Loralie J. [2 ]
Jannetto, Paul J. [2 ]
机构
[1] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China
[2] Mayo Clin, Rochester, MN USA
关键词
LOW BLOOD-CONCENTRATION; ADHERENCE; THERAPY; DISEASE; RECOMMENDATIONS; ASSOCIATION; CHLOROQUINE; MANAGEMENT; SURVIVAL; MARKER;
D O I
10.1002/acr.22837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo study the relationship between serum hydroxychloroquine (HCQ) concentrations and flares of systemic lupus erythematosus (SLE) in a longitudinal cohort of patients. MethodsPatients who fulfilled 4 American College of Rheumatology classification criteria for SLE and had been treated with HCQ for >6 months were studied. Blood was assayed for HCQ levels by tandem mass spectrometry. Patients were serially assessed for disease activity, using the Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) version of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and flares (SELENA flares instrument). Comparison of the mean summated SLEDAI scores over time and rates of flares in groups with different HCQ levels was performed by the Kruskal-Wallis test. ResultsA total of 276 SLE patients were studied (93% women, meanSD age 41.0 +/- 13.8 years). The proportion of patients with HCQ levels <10 (total noncompliance), 10-500 (subtherapeutic), and >500 ng/ml (therapeutic) was 11%, 77%, and 12%, respectively. HCQ levels correlated significantly with the prescribed dose but not with body weight or renal function. The prescribed HCQ dose also correlated significantly with baseline SLEDAI scores, indicating that higher doses were used for more active manifestations. After a mean +/- SD observation period of 32.5 +/- 5.5 months, the mean summated SLEDAI score and the incidence of SLE flares was not statistically different among patients with different baseline HCQ levels. In a subgroup of 73 patients with serologic and clinical remission and having therapeutic HCQ levels, a trend of lower disease activity and fewer incidences of flares was observed. ConclusionNoncompliance and subtherapeutic serum HCQ levels were seen frequently in these SLE patients, which was partly due to the low prescribed dose. In patients in remission, higher HCQ concentrations were associated with a trend showing fewer flares over time.
引用
收藏
页码:1295 / 1302
页数:8
相关论文
共 32 条
[1]   Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L) [J].
Alarcon, Graciela S. ;
McGwin, Gerald ;
Bertoli, Ana M. ;
Fessler, Barri J. ;
Calvo-Alen, Jaime ;
Bastian, Holly M. ;
Vila, Luis M. ;
Reveille, John D. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1168-1172
[2]   Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis [J].
Bertsias, George K. ;
Tektonidou, Maria ;
Amoura, Zahir ;
Aringer, Martin ;
Bajema, Ingeborg ;
Berden, Jo H. M. ;
Boletis, John ;
Cervera, Ricard ;
Doerner, Thomas ;
Doria, Andrea ;
Ferrario, Franco ;
Floege, Juergen ;
Houssiau, Frederic A. ;
Ioannidis, John P. A. ;
Isenberg, David A. ;
Kallenberg, Cees G. M. ;
Lightstone, Liz ;
Marks, Stephen D. ;
Martini, Alberto ;
Moroni, Gabriela ;
Neumann, Irmgard ;
Praga, Manuel ;
Schneider, Matthias ;
Starra, Argyre ;
Tesar, Vladimir ;
Vasconcelos, Carlos ;
van Vollenhoven, Ronald F. ;
Zakharova, Helena ;
Haubitz, Marion ;
Gordon, Caroline ;
Jayne, David ;
Boumpas, Dimitrios T. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) :1771-1782
[3]   The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial [J].
Buyon, JP ;
Petri, MA ;
Kim, MY ;
Kalunian, KC ;
Grossman, J ;
Hahn, BH ;
Merrill, JT ;
Sammaritano, L ;
Lockshin, M ;
Alarcón, GS ;
Manzi, S ;
Belmont, HM ;
Askanase, AD ;
Sigler, L ;
Dooley, MA ;
Von Feldt, J ;
McCune, WJ ;
Friedman, A ;
Wachs, J ;
Cronin, M ;
Hearth-Holmes, M ;
Tan, M ;
Licciardi, F .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (12) :953-962
[4]   Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus [J].
Costedoat-Chalumeau, Nathalie ;
Amoura, Zahir ;
Hulot, Jean-Sebastien ;
Aymard, Guy ;
Leroux, Gaelle ;
Marra, Donata ;
Lechat, Philippe ;
Piette, Jean-Charles .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (06) :821-824
[5]   Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus [J].
Costedoat-Chalumeau, Nathalie ;
Amoura, Zahir ;
Hulot, Jean-Sebastien ;
Abou Hammoud, Hala ;
Aymard, Guy ;
Cacoub, Patrice ;
Frances, Camille ;
Wechsler, Bertrand ;
Huong, Du Le Thi ;
Ghillani, Pascale ;
Musset, Lucile ;
Lechat, Philippe ;
Piette, Jean-Charles .
ARTHRITIS AND RHEUMATISM, 2006, 54 (10) :3284-3290
[6]   Adherence to treatment in systemic lupus erythematosus patients [J].
Costedoat-Chalumeau, Nathalie ;
Pouchot, Jacques ;
Guettrot-Imbert, Gaelle ;
Le Guern, Veronique ;
Leroux, Gaelle ;
Marra, Donata ;
Morel, Nathalie ;
Piette, Jean-Charles .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2013, 27 (03) :329-340
[7]   Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study) [J].
Costedoat-Chalumeau, Nathalie ;
Galicier, Lionel ;
Aumaitre, Olivier ;
Frances, Camille ;
Le Guern, Veronique ;
Liote, Frederic ;
Smail, Amar ;
Limal, Nicolas ;
Perard, Laurent ;
Desmurs-Clavel, Helene ;
Boutin, Du Le Thi Huong ;
Asli, Bouchra ;
Kahn, Jean-Emmanuel ;
Pourrat, Jacques ;
Sailler, Laurent ;
Ackermann, Felix ;
Papo, Thomas ;
Sacre, Karim ;
Fain, Olivier ;
Stirnemann, Jerome ;
Cacoub, Patrice ;
Jallouli, Moez ;
Leroux, Gaelle ;
Cohen-Bittan, Judith ;
Tanguy, Marie-Laure ;
Hulot, Jean-Sebastien ;
Lechat, Philippe ;
Musset, Lucile ;
Amoura, Zahir ;
Piette, Jean-Charles .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) :1786-1792
[8]   Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence [J].
Durcan, Laura ;
Clarke, William A. ;
Magder, Laurence S. ;
Petri, Michelle .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (11) :2092-2097
[9]  
ESDAILE J, 1991, NEW ENGL J MED, V324, P150
[10]  
Francès C, 2012, ARCH DERMATOL, V148, P479, DOI 10.1001/archdermatol.2011.2558